Alexander Panickacheril John

9PUBLICATIONS
2CO-AUTHORS
Metabolic medicineSensory processes, perception and performanceSocial program evaluationPersonality and individual differencesClinical nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 04, 2026
Reply to "Beyond Clozapine: Addressing Broader Metabolic Burden in Treatment-Resistant Schizophrenia".

Alexander P John, Hitesh Prajapati, Milan Dragovic

|Oct 30, 2025
Are cognitive deficits more severe among people with treatment-resistant schizophrenia than treatment responders?

Ananthakrishnan Koloth, Kim Yeak, Somayyeh Azimi

|Sep 04, 2025
Employment outcomes and their predictors among people with severe mental illness participating in an individual placement and support programme.

Amatul Bushra, Milan Dragovic, Marina Chalmers

|Aug 15, 2025
Metabolic Problems Among People With Treatment-Resistant Schizophrenia are Not Unique to Clozapine.

Alexander Panickacheril John, Hitesh Prajapati, Milan Dragovic

|Aug 29, 2024
Prevalence of treatment-resistant schizophrenia among people with early psychosis and its clinical and demographic correlates.

Mirza Detanac, Chelsey Williams, Milan Dragovic

|Nov 11, 2023
Cognitive deficits among people with schizophrenia and prediabetes or diabetes.

Alexander Panickacheril John, Thynn Mya, Darren Haywood

Pageof 2